ADmit Therapeutics
Impact sector
- Health
Industrial sector
- Biotech
Program
Ship2B Investment
- Equity4Good
- Investment network
Entrepreneurs
Description
Admit Therapeutics is a startup that focuses on the development and commercialization of a new technology for Alzheimer’s early detection. Their objective is to implement their test into clinical practice so patients can be referred to curative therapies as quickly as possible, thus improving their quality of life and their families.